Business Context and Reporting Period
This Form 8-K filing by Caribou Biosciences, Inc. (CRBU) reports on the results of the Annual Meeting of Stockholders held on September 20, 2022. The report was filed on September 21, 2022. The Company is incorporated in Delaware and trades on the NASDAQ Global Select Market.
Key Financial Metrics
This filing is a Current Report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
The filing details the final voting results for two proposals submitted to stockholders:
- Proposal 1: Election of Two Class I Directors
- Scott Braunstein: Elected with 24,250,029 votes for, 9,247,428 votes withheld, and 8,203,175 broker non-votes.
- Ran Zheng: Elected with 27,580,406 votes for, 5,917,051 votes withheld, and 8,203,175 broker non-votes.
- Both directors will serve until the 2025 annual meeting.
- Proposal 2: Ratification of Independent Registered Public Accounting Firm
- Stockholders ratified the selection of Deloitte & Touche LLP for the fiscal year ending December 31, 2022.
- Votes For: 41,151,707
- Votes Against: 319,238
- Votes Abstain: 229,687
Guidance, Outlook, and Risks
This filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It strictly reports the administrative outcome of the shareholder vote.
Important Facts for Investors to Verify
- Verify the total number of shares outstanding and the percentage of votes cast for each director to assess shareholder support levels.
- Review the definitive proxy statement (Schedule 14A) filed on August 11, 2022, for detailed biographies of the elected directors and the rationale for the auditor selection.
- Consult the Company's most recent 10-Q or 10-K filing for actual financial performance metrics, as this 8-K contains no financial data.